The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD
Brief Summary
This open-label fMRI study will assess the effects of a single dose of psilocybin on rumination and the neural correlates of rumination in individuals with treatment-resistant major depressive disorder.
Condition or Disease
- Treatment-Resistant Major Depressive Disorder
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Not yet recruiting |
| Study results: | No Results Available |
| Age: | 18 Years to 55 Years (Adult) |
| Enrollment: | 20 () |
| Funded by: | Other|Industry |
Masking |
|
Clinical Trial Dates
| Start date: | Jun 01, 2022 | |
|---|---|---|
| Primary Completion: | Jun 30, 2024 | |
| Completion Date: | Jun 30, 2024 | |
| Study First Posted: | May 19, 2022 | |
| Last Updated: | May 19, 2022 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Eligibility Criteria
| Sex: | All |
|---|
More Details
| NCT Number: | NCT05381974 |
|---|---|
| Other IDs: | 2021P000863 |
| Study URL: | https://ClinicalTrials.gov/show/NCT05381974 |
Last updated: Jun 17, 2022